Connect Biopharma (CNTB) announced the expansion of the size of its Board of Directors from six to seven directors and the appointment of Jim Schoeneck as a director effective today.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTB:
- Northland starts Connect Biopharma at Outperform on chance to define new class
- Connect Biopharma initiated with an Outperform at Northland
- Connect Biopharma Ends ADS Agreement with Deutsche Bank
- Connect Biopharma plans to terminate ADR program, list shares on Nasdaq
- Connect Biopharma Regains Nasdaq Compliance